Author:
Davison John,O’Shea Amy,Waterbury Nancee,Villalvazo Yolanda
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health(social science)
Reference11 articles.
1. Bansal, S., et al. (2015). Impact of all oral anti-hepatitis C virus therapy: A meta-analysis. World Journal of Hepatology, 7(5), 806–813.
2. Dominitz, J. A., et al. (2005). Elevated prevalence of Hepatitis C infection in users of United States veterans medical centers. Hepatology, 41(1), 88–96.
3. Bersoff-Matcha, S. J., et al. (2017). Hepatitis B virus reactivation associated with direct-acting antiviral therapy for chronic Hepatitis C virus: A review of cases reported to the US food and drug administration adverse event reporting system. Annals of Internal Medicine, 166(11), 792–798.
4. Russo, M. W., & Fried, M. W. (2003). Side effects of therapy for chronic Hepatitis C. Gastroenterology, 124(6), 1711–1719.
5. FDA (2016) Drug Safety Communication: FDA warns about the risk of Hepatitis B reactivating in some patients treated with direct-acting antivirals for Hepatitis C. FDA Drug Safety Communication.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献